Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences (Q44297138)

1 December 2017

title

Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences (English)

1 reference

1 December 2017

1 reference

1 reference

Khan Shoeb Zafar

1

1 reference

1 December 2017

Almas Siddiqui

2

1 reference

1 December 2017

Iqbal Sayeed

3

1 reference

1 December 2017

Muzamil Ahmad

4

1 reference

1 December 2017

Sofian Salim

5

1 reference

1 December 2017

Fakhrul Islam

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Journal of Neurochemistry

1 December 2017

published in

1 reference

1 December 2017

volume

84

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

438-446

1 reference

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Effects of Dietary Supplementation with Vitamin E, Riboflavin and Selenium on Central Nervous System Oxygen Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

The potential use of vitamin E and selenium in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Selenium deficiency as a cause of overload of iron and unbalanced distribution of other minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Oxidative stress, glutamate, and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

New animal models for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Methamphetamine-induced neuronal damage: a possible role for free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Oxidative stress and antioxidant therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Measurement of fluorescent lipid peroxidation products in biological systems and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Oxidative stress: free radical production in neural degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Reactive oxygen species and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Autoradiographic demonstration of uptake and accumulation of3H-6-hydroxydopamine in adrenergic nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Calcium ions and oxidative cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Parkinson's disease: a disorder due to nigral glutathione deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Effects of low selenium diets on antioxidant status and MPTP toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Regional distribution of glutathione peroxidase in the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Oxidative Damage to Behavior During Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

The uptake of Na-selenite in rat brain. Localization of new glutathione peroxidases in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Decreased serum selenium concentrations in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Assay of fluorescent lipid peroxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

Autoxidation and Neurotoxicity of 6-Hydroxydopamine in the Presence of Some Antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01531.X

10.1046/J.1471-4159.2003.01531.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference